Home / Programmes / Needleless Delivery

Advancing needleless drug delivery in Nigeria

A strategic initiative to pioneer needleless drug-delivery systems, support national vaccination campaigns and improve access to safer, more efficient therapies nationwide.

Needleless deliveryPublic healthProposed Initiative

The next evolution in drug delivery

Needleless drug delivery represents the next evolution in modern medicine, a safe, efficient and patient-friendly alternative to traditional injections. These technologies deliver medication through jet injectors, transdermal systems, inhalation and microneedle patches, eliminating conventional needles while still providing rapid, precise delivery. They reduce risks associated with needle use, infections, needle-stick injuries and improper disposal, and improve patient compliance, particularly among populations with needle aversion.

Why it matters for Nigeria

With an estimated 80,000 people who inject drugs (PWID) in Nigeria, needleless systems present an opportunity to reduce needle-related harm and disease transmission, support harm-reduction strategies, and improve public-health safety through reduced needle circulation. Needleless insulin delivery can improve adherence for patients requiring daily treatment; needleless vaccine delivery can enhance immunisation coverage by simplifying administration and improving safety during mass campaigns.

Alignment with national health priorities

Champions Pharmaceuticals proposes to support Nigeria’s healthcare modernisation through national immunisation programmes, vaccine-preventable disease control and expanding access to primary healthcare.

Proposed initiatives

  • Initiate a pilot programme, following required regulatory approvals including FDA authorisation for applicable needleless technologies.
  • Provide needleless drug-delivery equipment and infrastructure, programme logistics and supply-chain coordination, and technical support.
  • Expand access to innovative needleless therapies.
  • Deliver cost-effective, scalable solutions that make needleless therapies accessible to facilities nationwide.

A transformational opportunity

By reducing risks, improving patient compliance and enhancing the scalability of treatment and vaccination programmes, needleless delivery complements and strengthens existing healthcare infrastructure. Champions Pharmaceuticals is positioned to support Nigeria in adopting safer, more efficient drug-delivery systems.

Proposed initiative. The programmes described are proposed initiatives supporting national healthcare objectives, subject to relevant regulatory approvals. Champions Pharmaceuticals welcomes strategic dialogue with healthcare stakeholders and government agencies.

Contact our partnership team